Active Ingredient: NALOXONE HYDROCHLORIDE
Proprietary Name: NALOXONE HYDROCHLORIDE (AUTOINJECTOR)
Dosage Form; Route of Administration: SOLUTION; INTRAMUSCULAR, SUBCUTANEOUS
Strength: 10MG/0.4ML (10MG/0.4ML)
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N215457
Product Number: 001
Approval Date: Feb 28, 2022
Applicant Holder Full Name: KALEO INC
Marketing Status:
Discontinued
Patent and Exclusivity Information
